Capricor Therapeutics Inc (NASDAQ:CAPR)

4.16
Delayed Data
As of 3:59pm ET
 +0.06 / +1.46%
Today’s Change
2.81
Today|||52-Week Range
6.58
+7.77%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Capricor Therapeutics Inc have a median target of 15.00, with a high estimate of 18.00 and a low estimate of 12.00. The median estimate represents a +260.58% increase from the last price of 4.16.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Capricor Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.32
Sales
$1.0M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.23%
 
 
 
 
 
 
Growthannually 9.89%
 
 
 
 
 
 

Sales

Growthquarterly 4.18%
 
 
 
 
 
 
Growthannually 564.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.